🟢 Lantern Pharma is trading 10% up; catalyst remains unclear

Lantern Pharma is trading at $0.73, up +10.21%, with the catalyst unclear as of 9:50 a.m. ET on October 16, 2026.

• No clear company-specific announcement explaining the move was found for October 16.
• Lantern Pharma’s October 15 ThinkEquity presentation discussed its AI platform and oncology pipeline, but available reporting does not link it directly to the current gain.
• Biotech sector context is negative, with XBI down 2.06%, so it does not explain the stock’s rise. The specific catalyst remains unclear.